| Sep 17 |
EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm
|
| Sep 6 |
Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences
|
| Aug 10 |
Things Look Grim For Capricor Therapeutics, Inc. (NASDAQ:CAPR) After Today's Downgrade
|
| Aug 9 |
Capricor Therapeutics Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 9 |
Capricor Therapeutics, Inc. (CAPR) Q2 2024 Earnings Call Transcript
|
| Aug 7 |
Capricor Therapeutics (CAPR) Reports Q2 Loss, Misses Revenue Estimates
|
| Aug 7 |
Capricor: Q2 Earnings Snapshot
|
| Aug 7 |
Capricor Therapeutics GAAP EPS of -$0.35 beats by $0.01, revenue of $3.97M beats by $0.31M
|
| Aug 7 |
Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
| Aug 6 |
Capricor Therapeutics Q2 2024 Earnings Preview
|
